Bani Tamraz, PharmD, PhD

Title(s)Associate Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Address521 Parnassus Avenue, #3606
San Francisco CA 94117
Phone415-476-8013
ORCID ORCID Icon0000-0002-7341-455X Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, DavisB.S.Chemistry
    University of California, San FranciscoPharm.D.Pharmacy
    University of California, San FranciscoGeneral Practice Residency
    University of California,, San FranciscoPh.D.Pharmaceutical Sciences and Pharmacogenomics
    Collapse Awards and Honors
    University of California, Davis1998Dow Chemical Company Chemistry Scholarship
    American Association of Pharmaceutical Scientists2002  - 2003American Foundation for Pharmaceutical Education (AFPE) Gateway Research Scholarship
    University of California, San Francisco2006  - 2007Graduate Dean's Health Science Fellowship
    CHIH Foundation2008CHIH Foundation Fellowship Award
    Amgen2010  - 2011The Amgen Research Excellence in Biopharmaceutical Sciences Fellow
    Pharmacogenomics Research Network2019February Featured Investigator
    UCSF School of Pharmacy2019Twice recipient of Dean’s Apple Award in recognition of outstanding teaching spring/summer

    Collapse Overview 
    Collapse Overview
    My primary interest is identification of genetic determinants of drug response and translating that information into practical treatment strategies: Discovery to application. The MACS/WIHS Combined Cohort Study (MWCCS), formerly The Women’s Interagency HIV Study (WIHS) cohort, a multi-center longitudinal observational cohort, currently provides the perfect laboratory for conducting pharmacogenomics (PGx) research. I have nested several PGx studies within WIHS, providing me with the opportunity to examine how PGx factors interact with other pharmacokinetic factors to determine drug exposure and treatment outcome. In particular, my work with WIHS has enabled me to examine PGx variations associated with ethnicity which is an understudied, but high priority area of research. Besides PGx studies in HIV, I have studies in the areas of pediatric bone marrow transplant, ophthalmology and in vitro fertilization.

    In addition to discovery work, I am leading projects with an overarching vision of creating the UCSF Health-School of Pharmacy service for translating known PGx findings into clinical practice. At present, I am completing CLIA-certification of a gene panel that can provide PGx guidance for the use of 42 medications in UCSF Health. Following CLIA validation, the clinical application will be launched first with lung transplant service to pre-emptively genotype patients wait listed for transplant and use PGx to guide tacrolimus dosing post- transplant. I am leading several spin off projects related to clinical application of PGx at UCSF: a cost-effectiveness analysis of PGx in transplant and development of clinical decision support (CDS) structure for delivering the PGx-based treatment recommendations to clinicians.

    In summary, I have numerous active research projects, various collaborations and a growing clinical project that I am certain will produce meaningful results.

    Collapse Research 
    Collapse Research Activities and Funding
    Defining the impact of injection drug use on antiretroviral
    NIH R01DA047063-01Sep 3, 2018 - Jul 30, 2023
    Role: Site PI
    Description: Provide ongoing input on the use of WIHS data related to HIV treatment and medication usage, study design, analysis and interpretation of study findings and our in depth knowledge of the WIHS cohort data as it is related to HIV treatment and measures of medication usage and adherence.
    EpiGenomics of Ethnic and Racial Disparities in ARV Exposure and Treatment Outcomes
    NIH/NIMHD U01 AI034989Aug 25, 2017 - Dec 31, 2018
    Role: Co-Investigator
    Description: This study provides a comprehensive assessment of genes that may underlie ethnic and racial differences in ARV exposure and HIV treatment outcomes for two common regimens, and provide a robust framework to evaluate other regimens and outcomes (e.g., hypertension, type 2 diabetes) that feature ethnic and racial minority health disparities in both HIV+ and HIV- persons.
    Genetic risk factors for adverse drug responses and toxicities in women with HIV/AIDS
    NIH/NIGMS U01 AI034989Oct 1, 2016 - Jun 30, 2017
    Role: Co-Investigator
    Description: The purpose of this study is to define several adverse drug reactions and toxicities (ADR/T) in 4982 women who participated in WIHS, re-sequence 80 key candidate pharmacogenes and ADR/T genes and identify common genetic and non-genetic risk factors for ADR/T in the cohort.
    Needs assessment and value proposition for translation of pharmacogenomics into clinical practice at UCSF
    UCSF Medical Center: Chancellor's Strategic Initiative Funds Jul 1, 2016 - Jun 30, 2017
    Role: PI
    Description: The UCSF Health and UCSF leaders recognize precision medicine to be a priority. Pharmacogenetic (PG), an important component of precision medicine, is not commonly practiced at UCSF. For this project the objective is to develop needs assessment and value proposition for 1 or 2 therapeutic targets around the optimal translation of PG into clinical practice at UCSF; a blue–print that can be expanded in real-time to other therapeutic targets.
    GWAS analysis of atazanavir in two biomatrices from women in HIV
    Center For AIDS Research Program Supplement P30 A1027763Nov 1, 2014 - Oct 31, 2015
    Role: PI
    Description: Using Women’s Interagency HIV Study (WIHS) research platform to discover and validate gene polymorphisms associated with atazanavir exposure estimated by a combination of intensive pharmacokinetic and sparse hair levels.
    Personalized dosing strategies for use of fludarabine in pediatric alloHCT
    UCSF Clinical Translational Science Institute (CTSI) 5KL2TR000143-10Jul 1, 2013 - Jun 30, 2016
    Role: Co-investigator
    Description: The overall goal of this proposal is to develop innovative personalized dosing strategies for use of fludarabine in pediatric alloHCT to ensure safe and efficacious drug therapy in all patients. The research proposed in this application will identify and quantify both genetic and non-genetic covariates that contribute to variability in fludarabine exposure. This research will also establish the relationship between fludarabine exposure and clinical outcomes. I am involved in the pharmacogenetics of this work including sequencing DNA samples.
    Women’s Interagency HIV Study (WIHS) V
    NIH/NIAID U01 AI034989Dec 1, 1997 - Dec 31, 2020
    Role: Co-Investigator
    Description: The WIHS is the largest and longest-duration cohort study of HIV infection in women in the U.S. The San Francisco Bay Area WIHS (SF WIHS)’s aim feature special emphasis on vascular injury and pain, assess genetic contributions and examine the outcomes. We also continue our work in measuring long term exposure to antiretroviral drugs (ARVs) using hair samples and conducting Genome-Wide Association Studies. I am the pharmacogeneticist at SF WIHS.

    Collapse ORNG Applications 
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. 1606. Dual Trajectories of Antiretroviral Therapy Adherence and Polypharmacy in Women with HIV in the United Sate. Open Forum Infectious Diseases. 2023 Nov 27; 10(Supplement_2):ofad500.1441. SAEED SA, Ghebremichael GM, Konkle-Parker KD, Weiss WD, Collins CS, Adimora AA, Schneider SM, Cohen CM, Tamraz TB, Plankey PM, Wilson WT, adedimeji aA, Haberer HJ, Jacobson JD. .
      View in: Publisher Site   Mentions:
    2. Exploratory cohort study into underlying mechanism of differences in estrogen metabolism between Asian and Caucasian women during assisted reproductive technology treatment. F S Rep. 2023 Dec; 4(4):396-401. Kaing A, Adeleye A, Tamraz B, Fujimoto VY. PMID: 38204954; PMCID: PMC10774878.
      View in: PubMed   Mentions:
    3. 862-P: Reduced Metformin Clearance Is Associated with Increased Metformin-Related Side Effects in Older Adults with Type 2 Diabetes (T2D). Diabetes. 2023 Jun 20; 72(Supplement_1). YEN YK, SRINIVASAN SS, DAPKUS DL, TAMRAZ TB, MASHARANI MU, MCCABE MS, KROON KL. .
      View in: Publisher Site   Mentions:
    4. Dual trajectories of antiretroviral therapy adherence and polypharmacy in women with HIV in the United States. AIDS Res Ther. 2023 05 13; 20(1):29. Elbur AI, Ghebremichael M, Konkle-Parker D, Jones DL, Collins S, Adimora AA, Schneider MF, Cohen MH, Tamraz B, Plankey M, Wilson T, Adedimeji A, Haberer JE, Jacobson DL. PMID: 37179294; PMCID: PMC10182649.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Trajectories of Antiretroviral Therapy Adherence and Virologic Failure in Women With HIV in the United States. J Acquir Immune Defic Syndr. 2023 06 01; 93(2):162-170. Elbur AI, Ghebremichael M, Konkle-Parker D, Jones DL, Collins S, Adimora AA, Schneider MF, Cohen MH, Tamraz B, Plankey M, Wilson T, Adedimeji A, Haberer J, Jacobson DL. PMID: 36804871; PMCID: PMC10180014.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Dual Trajectories of Antiretroviral Therapy Adherence and Polypharmacy in Women with HIV in the United States. Res Sq. 2023 Jan 23. Elbur AI, Ghebremichael M, Konkle-Parker D, Jones DL, Collins S, Adimora AA, Schneider MF, Cohen MH, Tamraz B, Plankey M, Wilson T, Adedimeji A, Haberer JE, Jacobson DL. PMID: 36747684; PMCID: PMC9901001.
      View in: PubMed   Mentions:
    7. A Patient Decision Aid (i.ARTs) to Facilitate Women's Choice Between Oral and Long-Acting Injectable Antiretroviral Treatment for HIV: Protocols for its Development and Randomized Controlled Pilot Trial. JMIR Res Protoc. 2022 Sep 13; 11(9):e35646. Philbin MM, McCrimmon T, Shaffer VA, Kerrigan D, Pereyra M, Cohen MH, Sosanya O, Sheth AN, Adimora AA, Topper EF, Rana A, Tamraz B, Goparaju L, Wilson TE, Alcaide M. PMID: 36099004; PMCID: PMC9516368.
      View in: PubMed   Mentions: 2  
    8. Polypharmacy Is Associated With Falls in Women With and Without HIV. J Acquir Immune Defic Syndr. 2022 07 01; 90(3):351-359. Psomas CK, Hoover DR, Shi Q, Brown TT, Vance DE, Holman S, Plankey MW, Tien PC, Weber KM, Floris-Moore M, Bolivar HH, Golub ET, McDonnell Holstad M, Radtke KK, Tamraz B, Erlandson KM, Rubin LH, Sharma A. PMID: 35333216; PMCID: PMC9203977.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Degree of Polypharmacy and Cognitive Function in Older Women with HIV. AIDS Res Hum Retroviruses. 2022 07; 38(7):571-579. Rubin LH, Neijna AG, Shi Q, Hoover DR, Tamraz B, Anastos K, Edmonds A, Fischl MA, Gustafson D, Maki PM, Merenstein D, Sheth AN, Springer G, Vance D, Weber KM, Sharma A. PMID: 35357949; PMCID: PMC9297323.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. eP467 Are clinicians ready for genomic medicine?: assessing educational needs. Molecular Genetics and Metabolism. 2021 Apr 1; 132:s299. Ryan RM, Lindquist LK, Wandler WA, Morgan MC, Biswas BS, Flowers FE, Devine DP, Sparks ST, Scheuner SM, Tamraz TB, Hoffmann HT, Shieh SJ, Risch RN, Hyland HK. .
      View in: Publisher Site   Mentions:
    11. Association Between Medication-Taking and Refractive Error in a Large General Population-Based Cohort. Invest Ophthalmol Vis Sci. 2021 02 01; 62(2):15. Patasova K, Khawaja AP, Tamraz B, Williams KM, Mahroo OA, Freidin M, Solebo AL, Vehof J, Falchi M, Rahi JS, Hammond CJ, Hysi PG. PMID: 33591358; PMCID: PMC7900881.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    12. Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients. JAMA Netw Open. 2020 12 01; 3(12):e2029411. Ramsey LB, Ong HH, Schildcrout JS, Shi Y, Tang LA, Hicks JK, El Rouby N, Cavallari LH, Tuteja S, Aquilante CL, Beitelshees AL, Lemkin DL, Blake KV, Williams H, Cimino JJ, Davis BH, Limdi NA, Empey PE, Horvat CM, Kao DP, Lipori GP, Rosenman MB, Skaar TC, Teal E, Winterstein AG, Owusu Obeng A, Salyakina D, Gupta A, Gruber J, McCafferty-Fernandez J, Bishop JR, Rivers Z, Benner A, Tamraz B, Long-Boyle J, Peterson JF, Van Driest SL, IGNITE Pharmacogenetics Working Group. PMID: 33315113; PMCID: PMC7737091.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    13. Food Insecurity Is Associated With Lower Levels of Antiretroviral Drug Concentrations in Hair Among a Cohort of Women Living With Human Immunodeficiency Virus in the United States. Clin Infect Dis. 2020 09 12; 71(6):1517-1523. Leddy AM, Sheira LA, Tamraz B, Sykes C, Kashuba ADM, Wilson TE, Adedimeji A, Merenstein D, Cohen MH, Wentz EL, Adimora AA, Ofotokun I, Metsch LR, Turan JM, Bacchetti P, Weiser SD. PMID: 31608363; PMCID: PMC7486839.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    14. Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine. Antimicrob Agents Chemother. 2020 08 20; 64(9). Dumond JB, Bay CP, Nelson JAE, Davalos A, Edmonds A, De Paris K, Sykes C, Anastos K, Sharma R, Kassaye S, Tamraz B, French AL, Gange S, Ofotokun I, Fischl MA, Vance DE, Adimora AA. PMID: 32631821; PMCID: PMC7449168.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    15. CYP2C19 Allele Frequencies in Over 2.2 Million Direct-to-Consumer Genetics Research Participants and the Potential Implication for Prescriptions in a Large Health System. Clin Transl Sci. 2020 11; 13(6):1298-1306. Ionova Y, Ashenhurst J, Zhan J, Nhan H, Kosinski C, Tamraz B, Chubb A. PMID: 32506666; PMCID: PMC7719394.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    16. A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda. AIDS. 2019 11 01; 33(13):1995-2004. Patel RC, Stalter RM, Thomas KK, Tamraz B, Blue SW, Erikson DW, Kim CJ, Kelly EJ, Nanda K, Kourtis AP, Lingappa JR, Mugo N, Baeten JM, Scarsi KK, Partners PrEP Study Team. PMID: 31306173; PMCID: PMC6774811.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    17. Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women. Clin Pharmacol Ther. 2020 02; 107(2):315-318. Tamraz B, Huang Y, French AL, Kassaye S, Anastos K, Nowicki MJ, Gange S, Gustafson DR, Bacchetti P, Greenblatt RM, Hysi PG, Aouizerat BE, Women's Interagency HIV Study. PMID: 31562781; PMCID: PMC10810687.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    18. Association between Use of Methadone, Other Central Nervous System Depressants, and QTc Interval-Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus Infection. Pharmacotherapy. 2019 09; 39(9):899-911. Tamraz B, Reisner L, French AL, King ST, Fischl MA, Ofotokun I, Kashuba A, Milam J, Murphy K, Augenbraun M, Liu C, Finley PR, Aouizerat B, Cocohoba J, Gange S, Bacchetti P, Greenblatt RM. PMID: 31332819; PMCID: PMC7000174.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. A practical first step using needs assessment and a survey approach to implementing a clinical pharmacogenomics consult service. Journal of American College of Clinical Pharmacy. 2019; 2(3):214-221. Zakinova, Angela, Long-Boyle, Janel R., French, Deborah, Croci, Rhiannon, Wilson, Leslie, Phillips, Kathryn A., Kroetz, Deanna L., Shin, Jaekyu., Tamraz, Bani. View Publication.
    20. A Practical First Step Using Needs Assessment and a Survey Approach to Implementing a Clinical Pharmacogenomics Consult Service. J Am Coll Clin Pharm. 2019 Jun; 2(3):214-221. Zakinova A, Long-Boyle JR, French D, Croci R, Wilson L, Phillips KA, Kroetz DL, Shin J, Tamraz B. PMID: 32391517; PMCID: PMC7207007.
      View in: PubMed   Mentions: 5  
    21. Ascorbic acid metabolites are involved in intraocular pressure control in the general population. Redox Biol. 2019 01; 20:349-353. Hysi PG, Khawaja AP, Menni C, Tamraz B, Wareham N, Khaw KT, Foster PJ, Benet LZ, Spector TD, Hammond CJ. PMID: 30391827; PMCID: PMC6223183.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    22. Development and validation of an LC-MS/MS assay for the quantification of dolutegravir extracted from human hair. Anal Bioanal Chem. 2018 Nov; 410(29):7773-7781. Sykes C, Blake K, White N, Schauer AP, Guzman BB, Cottrell ML, Tamraz B, Kashuba ADM. PMID: 30280227; PMCID: PMC6501839.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Cognitive Burden of Common Non-antiretroviral Medications in HIV-Infected Women. J Acquir Immune Defic Syndr. 2018 09 01; 79(1):83-91. Rubin LH, Radtke KK, Eum S, Tamraz B, Kumanan KN, Springer G, Maki PM, Anastos K, Merenstein D, Karim R, Weber KM, Gustafson D, Greenblatt RM, Bishop JR. PMID: 29781879; PMCID: PMC6092212.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    24. A Genome-Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair. Clin Pharmacol Ther. 2018 11; 104(5):949-956. Tamraz B, Huang Y, French AL, Kassaye S, Anastos K, Nowicki MJ, Gange S, Gustafson DR, Bacchetti P, Greenblatt RM, Hysi PG, Aouizerat BE. PMID: 29315502; PMCID: PMC6037621.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Pharmacogenetic Associations with ADME Variants and Virologic Response to an Initial HAART Regimen in HIV-Infected Women. Int J HIV AIDS Res. 2017; 4(3):154-160. Pearce CL, Stram D, Wiensch A, Frasco MA, Kono N, Den Berg DV, Anastos K, Cohen MH, DeHovitz J, Golub ET, Tamraz B, Liu C, Mack WJ. PMID: 29577081; PMCID: PMC5863915.
      View in: PubMed   Mentions:
    26. OATP1B1-related drug-drug and drug-gene interactions as potential risk factors for cerivastatin-induced rhabdomyolysis. Pharmacogenet Genomics. 2013 Jul; 23(7):355-64. Tamraz B, Fukushima H, Wolfe AR, Kaspera R, Totah RA, Floyd JS, Ma B, Chu C, Marciante KD, Heckbert SR, Psaty BM, Kroetz DL, Kwok PY. PMID: 23652407; PMCID: PMC3894639.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    27. A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrel. Clin Pharmacol Ther. 2012 May; 91(5):896-904. Floyd JS, Kaspera R, Marciante KD, Weiss NS, Heckbert SR, Lumley T, Wiggins KL, Tamraz B, Kwok PY, Totah RA, Psaty BM. PMID: 22419147; PMCID: PMC3830936.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    28. Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenet Genomics. 2011 May; 21(5):280-8. Marciante KD, Durda JP, Heckbert SR, Lumley T, Rice K, McKnight B, Totah RA, Tamraz B, Kroetz DL, Fukushima H, Kaspera R, Bis JC, Glazer NL, Li G, Austin TR, Taylor KD, Rotter JI, Jaquish CE, Kwok PY, Tracy RP, Psaty BM. PMID: 21386754; PMCID: PMC3076530.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    29. Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis. Pharmacogenet Genomics. 2010 Oct; 20(10):619-29. Kaspera R, Naraharisetti SB, Tamraz B, Sahele T, Cheesman MJ, Kwok PY, Marciante K, Heckbert SR, Psaty BM, Totah RA. PMID: 20739906; PMCID: PMC2993694.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    30. Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations. J Allergy Clin Immunol. 2009 Nov; 124(5):1099-105.e1-4. Trivedi NN, Tamraz B, Chu C, Kwok PY, Caughey GH. PMID: 19748655; PMCID: PMC2783561.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    31. An Inactivating, Frame-shifted Mutation of ,III Tryptase is Common in People of Northern and Western European Ancestory. Journal of Allergy and Clinical Immunology. 2009 Mar 1; 123(3):728-729. Trivedi TN, Tamraz TB, Kwok KP, Caughey CG. .
      View in: Publisher Site   Mentions:
    32. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am J Hum Genet. 2007 Apr; 80(4):716-26. Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, Tandon A, Choy E, Hu D, Tamraz B, Pawlikowska L, Wassel-Fyr C, Huntsman S, Waliszewska A, Rossin E, Li R, Garcia M, Reiner A, Ferrell R, Cummings S, Kwok PY, Harris T, Zmuda JM, Ziv E, Health, Aging and Body Composition (Health ABC) Study. PMID: 17357077; PMCID: PMC1852718.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Bani's Networks
    Concepts (176)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.